[HTML][HTML] The analgesic potential of cannabinoids

J Elikottil, P Gupta, K Gupta - Journal of opioid management, 2009 - ncbi.nlm.nih.gov
Historically and anecdotally cannabinoids have been used as analgesic agents. In recent
years, there has been an escalating interest in developing cannabis-derived medications to …

Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?

J Turna, B Patterson… - Depression and …, 2017 - Wiley Online Library
Anxiety and related disorders are the most common mental conditions affecting the North
American population. Despite their established efficacy, first‐line antidepressant treatments …

Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders

T Bisogno, V Di Marzo - … (Formerly Current Drug Targets-CNS & …, 2010 - ingentaconnect.com
The G-protein coupled receptors for Δ9-tetrahydrocannabinol, the major psychoactive
principle of marijuana, are known as cannabinoid receptors of type 1 (CB1) and 2 (CB2) and …

[PDF][PDF] Pharmacological management of persistent pain in older persons

O Persons - J Am Geriatr Soc, 2009 - acclaimhealth.ca
Pain is a complex phenomenon caused by noxious sensory stimuli or neuropathological
mechanisms. An individual's memories, expectations, and emotions modify the experience …

Stigma among California's medical marijuana patients

TD Satterlund, JP Lee, RS Moore - Journal of psychoactive drugs, 2015 - Taylor & Francis
The enactment of California's Proposition 215 stipulates that patients may use marijuana for
medical reasons, provided that it is recommended by a physician. Yet, medical marijuana …

Efficacy and safety of medical cannabinoids in older subjects: a systematic review

GAH van den Elsen, AIA Ahmed, M Lammers… - Ageing research …, 2014 - Elsevier
This systematic review aims to integrate the evidence on indications, efficacy, safety and
pharmacokinetics of medical cannabinoids in older subjects. The literature search was …

Nabiximols in chronic neuropathic pain: a meta-analysis of randomized placebo-controlled trials

I Dykukha, R Malessa, U Essner, MA Überall - Pain Medicine, 2021 - academic.oup.com
Objective Pooled analysis of nabiximols and placebo in randomized controlled studies
(RCTs) of chronic neuropathic pain. Design Systematic review and meta-analysis. Methods …

[HTML][HTML] IUPHAR review: Navigating the role of preclinical models in pain research

SA Karimi, FT Zahra, LJ Martin - Pharmacological Research, 2024 - Elsevier
Chronic pain is a complex and challenging medical condition that affects millions of people
worldwide. Understanding the underlying mechanisms of chronic pain is a key goal of …

Cannabinoids as immune system modulators: Cannabidiol potential therapeutic approaches and limitations

A Aziz, LC Nguyen, L Oumeslakht… - Cannabis and …, 2023 - liebertpub.com
Introduction: Cannabidiol (CBD) is the second most abundant Phytocannabinoid in
Cannabis extracts. CBD has a binding affinity for several cannabinoid and cannabinoid …

[HTML][HTML] An exploratory human laboratory experiment evaluating vaporized cannabis in the treatment of neuropathic pain from spinal cord injury and disease

B Wilsey, TD Marcotte, R Deutsch, H Zhao, H Prasad… - The journal of pain, 2016 - Elsevier
Using 8-hour human laboratory experiments, we evaluated the analgesic efficacy of
vaporized cannabis in patients with neuropathic pain related to injury or disease of the …